HelloBiome provides an AI-powered platform that integrates Next-Generation sequencing for detailed microbiome analysis across facial, scalp, body, and vulva microbiomes. The company offers data services for remote claim studies, clinical research, and white-label kit solutions. This technology delivers precise, data-driven insights to support product innovation and personalization in the life sciences sector.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Understanding and leveraging the human microbiome for product development and personalized recommendations is complex. Current methods often lack the precision and scalability required for in-depth analysis of microbial communities across different body sites.
Solution
HelloBiome provides an AI-powered platform that integrates next-generation sequencing with proprietary machine learning algorithms to deliver precise microbiome insights. Our service analyzes bacterial and fungal species at a granular level, enabling detailed characterization of microbiomes from various body sites, including facial, scalp, body, and vulvar regions. This data facilitates the development of innovative products, supports remote clinical claim studies, and allows for the creation of personalized recommendations. We offer a flexible service model that supports both research and commercial applications, with results typically available within 48 hours of sample receipt at our CLIA-certified and CAP-accredited laboratory partner.
Target Audience
Our primary customers are companies in the beauty, skincare, and wellness industries, as well as contract research organizations (CROs) and academic institutions focused on microbiome research and product innovation.
Features
- Next-generation DNA sequencing for species-level analysis of bacteria and fungi.
- Proprietary, patent-pending AI technology for automated microbiome data analysis and recommendation generation.
- CLIA-certified and CAP-accredited laboratory partner for high-accuracy sample processing.
- Support for remote clinical studies, including before/after claim assessments.
- Development of white-label commercial kits with customized product recommendations.
- Analysis of diverse microbiome sites, including facial, scalp, body, and vulvar regions.
- Rapid data turnaround, with results available within 48 hours of lab delivery.
- Formulation consultancy and end-to-end guidance for microbiome-driven product development.